Literature DB >> 19422446

Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice.

J-G Wang1, D Manly, D Kirchhofer, R Pawlinski, N Mackman.   

Abstract

BACKGROUND: Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called microparticles (MPs). Elevated levels of these MPs appear to play a role in the pathogenesis of thrombosis in a variety of diseases, including sepsis.
OBJECTIVE: Measure levels of MP TF activity and activation of coagulation in control and endotoxemic mice.
MATERIALS AND METHODS: MPs were prepared from plasma by centrifugation. The procoagulant activity (PCA) of MPs was measured using a two-stage chromogenic assay. We also measured levels of thrombin-antithrombin and the number of MPs.
RESULTS: Lipopolysaccharide (LPS) increased MP PCA in wild-type mice; this PCA was significantly reduced by an anti-mouse TF antibody (1H1) but not with an anti-human TF antibody (HTF-1). Conversely, in mice expressing only human TF, MP PCA was inhibited by HTF-1 but not 1H1. MPs from wild-type mice had 6-fold higher levels of PCA using mouse factor (F)VIIa compared with human FVIIa, which is consistent with reported species-specific differences in FVIIa. Mice expressing low levels of human TF had significantly lower levels of MP TF activity and TAT than mice expressing high levels of human TF; however, there were similar levels of phosphatidylserine (PS)-positive MPs. Importantly, levels of MP TF activity in wild-type mice correlated with levels of TAT but not with PS-positive MPs in endotoxemic mice.
CONCLUSION: These results suggest that the levels of TF-positive MPs can be used as a biomarker for evaluating the risk of disseminated intravascular coagulation in endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422446      PMCID: PMC2838714          DOI: 10.1111/j.1538-7836.2009.03448.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  40 in total

1.  Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.

Authors:  V Y Bogdanov; G Cimmino; J G Tardos; J R Tunstead; J J Badimon
Journal:  J Thromb Haemost       Date:  2009-02-12       Impact factor: 5.824

2.  Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.

Authors:  S A Gregory; J H Morrissey; T S Edgington
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

3.  The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.

Authors:  R F Franco; E de Jonge; P E Dekkers; J J Timmerman; C A Spek; S J van Deventer; P van Deursen; L van Kerkhoff; B van Gemen; H ten Cate; T van der Poll; P H Reitsma
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

4.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

Authors:  Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner
Journal:  Nat Med       Date:  2003-07-13       Impact factor: 53.440

5.  Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

Authors:  E Biró; K N Sturk-Maquelin; G M T Vogel; D G Meuleman; M J Smit; C E Hack; A Sturk; R Nieuwland
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

6.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

Authors:  Rafal Pawlinski; Brian Pedersen; Gernot Schabbauer; Michael Tencati; Todd Holscher; William Boisvert; Patricia Andrade-Gordon; Rolf Dario Frank; Nigel Mackman
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

7.  An inhibitory monoclonal antibody against human tissue factor.

Authors:  S D Carson; S E Ross; R Bach; A Guha
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

8.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.

Authors:  Vladimir Y Bogdanov; Viji Balasubramanian; James Hathcock; Oana Vele; Mark Lieb; Yale Nemerson
Journal:  Nat Med       Date:  2003-03-24       Impact factor: 53.440

9.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

Authors:  Omer Aras; Arun Shet; Ronald R Bach; Jessica L Hysjulien; Arne Slungaard; Robert P Hebbel; Gines Escolar; Bernd Jilma; Nigel S Key
Journal:  Blood       Date:  2004-02-26       Impact factor: 22.113

View more
  56 in total

1.  Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.

Authors:  Alice Chanakira; Pamela R Westmark; Irene M Ong; John P Sheehan
Journal:  Gynecol Oncol       Date:  2017-01-29       Impact factor: 5.482

2.  Microparticles during sepsis: target, canary or cure?

Authors:  Lara Zafrani; Can Ince; Peter S T Yuen
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

3.  Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Authors:  Jian-Guo Wang; Julie C Williams; Beckley K Davis; Ken Jacobson; Claire M Doerschuk; Jenny P-Y Ting; Nigel Mackman
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

4.  Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.

Authors:  M M Aleman; C Gardiner; P Harrison; A S Wolberg
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

5.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Authors:  Lara Zafrani; Grigoris Gerotziafas; Colleen Byrnes; Xuzhen Hu; Joelle Perez; Charlène Lévi; Sandrine Placier; Emmanuel Letavernier; Asada Leelahavanichkul; Jean-philippe Haymann; Ismail Elalamy; Jeffrey L Miller; Robert A Star; Peter S T Yuen; Laurent Baud
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

6.  Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Authors:  J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman
Journal:  J Thromb Haemost       Date:  2015-12-11       Impact factor: 5.824

Review 7.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 8.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

10.  Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction.

Authors:  Birgit A Steppich; Siegmund Lorenz Braun; Andreas Stein; Gabriele Demetz; Philip Groha; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati; Ilka Ott
Journal:  Thromb J       Date:  2009-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.